Theoretical and practical issues involved in integrating pharmocotherapy and psychosocial therapy in a long-term day hospital for schizophrenics are addressed. The limitations and risks of relying too heavily on a biomedical conceptual framework are discussed. In addition to diagnosis, target symptoms, pharmacodynamics, and pharmacokinetics, individual interpersonal, family, and institutional dynamics can exert profound effects on the effectiveness of medication. Through case illustrations it is shown how an open systems model and a group approach can allow for an integration of the many variables involved in the medication process. A weekly medication group which emphasizes education, informed choice, patient responsibility, and the examination of the boundary between medication effect and the need for psychological work is described. It is shown that the chemical control of psychosis alone may reinforce the psychosocial aspects of the schizophrenic syndrome. A distinction is drawn between chemical control of psychosis and the sensitive use of medication as a facilitator of growth-promoting psychosocial treatment.
placenta previa birth and a seizure at age three had led to her daughter's disordered brain, requiring her to be protected and controlled. Independence was out of the question. Mother insisted that Carol had a memory defect; her evidence was that Carol responded to such questions as "What happened in school today?" by answering, "Nothing." When I recommended more family meetings and raised questions about Carol's alleged "defective mind" based on my experience with Carol, her mother triumphantly handed me a copy of The Broken Brain with the following passage underlined:
"While episodes of illness are sometimes triggered by unfortunate life events, the basic causes lie in the biology of the brain. The best way to treat these biological abnormalities-treatment that is not always available at present-is to correct the underlying physical abnormality, usually through the use of somatic therapy" [1] .
This book heralds the remarkable advances in biological psychiatry as the beginning of a psychiatric revolution that will lead to a brave new world for sufferers of mental illness in which no one will experience blame, stigma, or guilt. Mental patients will be treated with compassion and chemicals. Carol, in her flight from the hospital, was reacting to a meta-level message contained within the superficially more benevolent one. She experienced the insistence on fixing her broken brain as an invalidation of her perceptions and her healthy ego strivings.
Like the doctor from whom Carol was running, it occurred to me as a psychiatrist of the 1980s that Carol needed a neuroleptic despite what she had to say against it: she was suffering from a thought disorder. The collaborative NIH study [2] , the May study [3] , and many more like them demonstrate the efficacy of neuroleptics and their superiority over all other interventions. The Rosenthal and Kety studies [4] demonstrating genetic factors in schizophrenia, the new technologies on the brink of establishing biological markers, neurotransmitter research, and the plethora of articles and accounts in the media about schizophrenia being a chemical imbalance that my patients' families bring to me on a regular basis-these seemed compelling reasons why I should reach for a pill or a syringe to get a neuroleptic into Carol. If I did not find a way to get Carol to comply, might there be grounds for a malpractice suit?
On the other hand, I admired Carol's spark of healthy ego trying to fight off psychotic collapse, as she tried to hold her own in a conflict of interest with her family and to strike out on her own. It also seemed to me that in some ways Carol was being more scientific than the biological psychiatrists by insisting that her problems could not be understood without understanding her family's role.
While the modern technology of biological psychiatry is impressive, the more profound scientific revolution, however, is an epistemological shift from an Aristotelian linear cause-and-effect model of thinking to a systems framework which is predicated on multiple causation and complex interrelationships. In his last work, Levels of Schizophrenia, Scheflen [5] examines this revolution as it pertains to schizophrenia. Unlike Szas, who believes that schizophrenia is a bogus category manufactured by society and the mental health establishment, Scheflen maintains that schizophrenia is quite real, but too complex to fit into a DSM-type categorization, with its exclusive focus on the illness of an individual. He delineates a system of eight interacting levels to describe the schizophrenic syndrome: the neural fields, the neurotransmission system, the nervous system, the schizophrenic person, the dyadic relationship, the family, mental health institutions, and society. Failure at one level of organization can be rectified by processes or interventions at the next higher level of organization or deviance can be increased by non-compensating responses. If there is not sufficient rectification at each successive level, deviance reaches a critical point at which, in cybernetic terms, there is a runaway situation manifesting as a psychotic disorganization in the vulnerable schizophrenic person.
Observing a living social system is analogous to examining a smaller, biological system through a microscope. The different size and appearance of the fields that we see at different magnifications depend on focus and perspective, but each level interacts with and affects every other level. The same is true in a schizophrenic system. A dysfunction of neural fields or the neurotransmitter in the limbic system, perhaps genetically determined, could be either compensated for or exacerbated by the mother's response at the dyadic level. Problems of mother-infant responsiveness could be compensated for or exacerbated by the family's response to the problems in the dyad. The family in turn is affected by the response of the mental health system, and the mental health system by society and its institutions. Findings from anthropology of dramatic differences in the outcome in schizophrenia between third-world and western cultures, findings from neurophysiology which suggest that quality of interaction and the early experience of the infant have bearing on proliferation of neural networks (Scheflen [5] [7] , in their psychosocial biological development model of schizophrenia, stress the maturational arrest in the schizophrenic that leaves the individual socially inept, dependent on a symbiosis-like attachment, and vulnerable to the emotional fallout that is a by-product of relationships with others. The schizophrenic is on the horns of the need/fear dilemna and seeks sanctuary in psychosis or withdrawn states of non-experience (Ogden [8] Our day program in Washington, D.C., is housed in an old school building. This seems fitting, since our philosophy stresses learning more than the treatment of disease. Our census averages 20 to 25 patients; duration of treatment ranges from several months to several years. The vast majority of our patients have had more than one psychotic episode and several previous inpatient hospitalizations; most carry the diagnosis of schizophrenia. For the most part, they live in the community in halfway houses, in group homes, and a few in apartments. They are trying to make an adjustment to life in the community rather than in a state hospital.
As a result of budget cuts three years ago, we lost a psychiatrist's position, requiring me to take on the role of pharmacotherapist in addition to my role as clinical director, sociotherapist, and group and family therapist. It has been a great surprise to me to find that it is in the role of pharmacotherapist that I have had to grapple most directly with pressures from patients, families, and other treatment systems that threaten to subvert the fundamentals of our treatment philosophy. The notion that schizophrenia is just a chemical imbalance that can be fixed by a chemical is legitimized in the minds of patients and family by the swing to biological psychiatry in the media. It is this myth that is often invoked when fears and tensions in the therapeutic process run high; it can present a formidable resistance to therapeutic work.
In a multiple family group, Jim complained that his father had been swearing and screaming at him for weeks and that he was afraid that this might drive him to retaliate. His mother had earlier revealed that Jim's father, who does not attend the meetings, was having a hard time adjusting to imminent retirement. At this point, however, she disregarded her son's protest and complained to the therapist that Jim was not taking his medication regularly. "I read an article in the newspaper by Dr. Fuller Torrey," she continued, "that schizophrenia is caused by a chemical imbalance in the brain, and Jim is certainly out of balance." Efforts by the co-therapists to encourage her to consider what Jim was saying were drowned out by her escalating complaints to the psychiatrist for not being forceful enough with Jim's medication. Two other mothers joined the attack on the psychiatrist in support of Jim's mother, asserting that their sons are fine when they take their medication but don't make any sense when they don't. Bill, a recovering schizophrenic who hasn't had a psychotic episode in four years, then tried to get Jim's mother to listen to her son. He recounted his struggle with his parents to take his feelings seriously instead of jamming a pill down his throat when he got angry. At first Jim's mother attacked and tried to discredit Bill, but when Bill's mother echoed Bill's position, Jim's mother began to consider that perhaps she should listen to her son. The beginnings of a dialogue between Jim and his mother ensued in which they discussed their common problem with Jim's depressed, angry father. The work on expressed emotionality and the development of non-exploratory educational approaches in family therapy represent a promising direction that appreciates the vulnerability of the schizophrenic member and the importance of a positive treatment alliance with the family (Brown et al. [9] ). Recent evidence suggests that approaches embodying these insights can be effective in minimizing the noxious effects of blaming, excessive guilt, and acrimony, and reduce the incidence of psychotic flareups. If the unconscious tendency to lock the schizophrenic into a role in which observations, thoughts, and feelings are invalidated is not addressed, however, the non-psychotic part of the schizophrenic condition can be deepened. As in Jim's case, if the reductionism that schizophrenia is just a chemical imbalance is supported by the therapist, the result is also support for pathological symbiosis, denial of the obvious rift between mother and father, and invalidation of the patient's accurate perceptions.
Many patients believe that they are incapable of thinking and feeling in any constructive way. Ogden suggests that the withdrawn non-responsive states where many schizophrenics spend a great deal of their time are manifestations of the schizophrenic's identification with the part of the mother who could not receive and metabolize their projections as infants. He theorizes that, as a result of this internalization, the potential schizophrenic literally shuts off the apparatus in the brain necessary to receive and process experience, thus accounting for the maturational arrests. Medication used inappropriately when feelings are beginning to awaken in the patient can reinforce the patient's conviction that he cannot learn by experience.
Jane is a 36-year-old recovering schizophrenic who spent her adolescence through age 28 as a revolving-door schizophrenic with frequent psychotic exacerbations. While a patient at our day hospital, an outside psychiatrist gave her megadoses of tranquilizers and neuroleptics, as well as several courses of ECT, that blotted out feelings and thoughts each time she seemed on the threshold of making developmental steps. Jane has now been working with me in individual psychotherapy for the past several years. She is living on her own, working, and has been free of psychotic relapses for six years. She has recently noticed that the frequent nightmarish feeling, at times a delusion, that her brain is being sliced to pieces, follows times of anger or awareness of thoughts that she feels are likely to be controversial. We have come to understand that this state is an internalization of her experience that her mother could not stand for her to think or feel. Thus, symbolically she destroys her brain in order to protect her symbiotic attachment to her mother. When her doctor used excessive medication or ECT, often at her request, he lived out the transference and deepened her despair. The challenging task for me as the day hospital pharmacotherapist has been to prescribe medication in a way that helps the patient reduce emotional turbulence and psychotic remissions without joining the unconscious forces within the patient, the family, the treatment system, and within myself, that abort the process of learning through experience and the development of capacities to think and feel.
To work with these problems, our program established a medication group. It meets weekly for an hour and fifteen minutes and is open to all patients taking medication as well as to other patients and staff who are interested. Despite the fact that the emphasis in our program is psychosocial, we felt that such a group was needed to recognize that medication plays a central role in the lives of many of the patients and has enabled many of them to decrease the frequency and severity of psychotic episodes. Rather than thinking of our task as increasing or ensuring compliance, we have tried to engender a culture in which patients are responsible for making choices about medication based on information, recommendations from the pharmacotherapist, and consultation with the group. An approach which emphasizes compliance implies a passive-dependent role for the patient that resonates with symbiotic family relationships. These strategies often validate patients' feelings of powerlessness and paranoid thinking. Our We often consider the role of life style, diet, exercise, and deleterious effects of non-prescription drugs such as stimulants and street drugs. The patient is helped by the group to sort through which of his or her difficulties are amenable to medication, which require psychological work. We look at the possible investment in being psychotic as a life choice. Rather than exploiting transference or using indoctrination techniques, the patient is encouraged to make an informed choice about medication based on the best scientific information with recommendations from the group and the doctor. It is understood that the doctor will not prescribe any medication that is likely to be harmful to the patient.
At times, the exigencies of a group process with disturbed patients requires an active focusing on my part, or process-oriented interventions, to restore a work group in the face of basic assumption pressure. For the most part, though, the group format has provided much richer examination and working through than individual medication transactions. The prescribing of a substance to be taken into the body through the mouth during moments of distress is likely to evoke in the patient intense feelings reminiscent of the infant-mother breastfeeding experience. If the introjects of the bad poisonous destructive breast have not been adequately metabolized, as they rarely have been in the schizophrenic patient, then the patient may well experience at a conscious or unconscious level the medication process as an attempt to poison, destroy, or envelop him. The doctor, in turn feeling himself to be perceived as destructive, may be pushed to defensive postures to protect himself from damage to his own self-esteem. The group provides a buffer against this situation, diffusing its intensity and introducing ego-oriented concerns. The mother-child dyad is less compellingly recreated. The group assists the patient and the doctor to negotiate in the emotion-laden process of giving and taking in.
In a recent medication group, John requested that I prescribe an antihypertensive drug for him. He had been taking Prolixin but also uses whatever street drugs he can get when he feels emotional pain. John seems to have concluded that drugs are the only answer to problems or pain. This belief has been reinformed by similar attitudes in his family, in which his father is an alcoholic and his mother uses Valium heavily. A previous psychiatrist had put John on megadoses of neuroleptics, focusing treatment on his lack of compliance with medication. I responded naively to John's request for an anti-hypertensive drug that I didn't know he had a blood-pressure problem. John explained that he meant an anti-tension drug. He described feeling a burning inside when he tries to have "an eye to eye" with a person who is "against" him. Another patient asked him who his conflict was with, to which John responded irritably that he was fed up with talking therapy and wanted a "soothing from a drug." I responded that the Prolixin he was taking with pro re nata provision was probably the best anti-tension medication for him at this time. We could consider other medications in that class, but this might be a matter of the limits of medication. Perhaps he needed to work on how to be in conflict with another person and accept and manage the angry feeling. John boomed back that I make him swallow the damned Prolixin that keeps him dopey and under my thumb; that I have a panacea but just won't let him have it. I suggested we could explore the possibility that a lower dose of Prolixin might help. He exploded, "You people have me in a bind! I get all cut up by my family if I don't swallow what they want. My mother can get any goddamned happiness pill she wants but you won't do the same for me." At this point I felt a counter-surge of anger that this fellow was being infuriating. While I was trying to sort through the projections and countertransference, several patients intervened to remind John that I had not forced him to take anything and that he has to learn to experience some uncomfortable feelings. Another patient shouted at John that he wanted to have his cake and eat it, too-"Stop being such a baby!" John flushed and stood up as if to leave the room, but Janice, another patient, asked him to stay. For many years she had had numerous psychotic episodes requiring hospitalizations that had been fueled by street drugs. She and I had enacted many similar confrontations in the past, but for the last three years she had been free of psychosis and had been struggling to face reality without numbing drugs. She and John were friends, and I felt that at this moment her credentials with John were better than mine, despite her paranoid style and persistent delusion that she was the messenger of God. She told the group that we must be patient with John because he was trying to help himself. She shared feelings about how hard it is to face life without escapes and delusions or drugs when reality seems so barren and pointless. Tempers cooled, and John and I then were able to work out an accommodation which involved continuing the Prolixin and trying to use therapy groups and trusted people to help him manage painful or overwhelming feelings. While John has continued to knock out his thinking and feeling capacities -under stress, either through drugs or withdrawal, slowly he is bringing more of himself into the community, and the group's ability to contain his projections and rage are helping to develop trust.
The medication group has been an invaluable place to work on the complex interplay of the physiological, intrapsychic, interpersonal, and social aspects of the medication process. Medical dynamics, however, extend into all phases of the program and particularly exert influence on the boundary between our program and families, outside mental health institutions, and other people and institutions involved in the patient's network. As Scheflen points out, in addition to the therapeutic and altruistic motives that are elicited by the schizophrenic's painful predicament, there is an unconscious investment in keeping him schizophrenic. The symbiotic partner needs a partner; the family needs a repository, or glue; the hospitals and halfway houses need customers; and society needs the insane as a frame of reference and as a basis for exerting social control outside of the legal domain. The patient colludes with those forces to the extent to which he is invested in a career as a chronic mental patient. Medication can also be used as a chemical and symbolic restraint to help keep the patient locked in the disenfranchised schizophrenic role, thus maintaining the equilibrium of the system.
The interplay of these forces emerged dramatically in our work with Tom, a thirty-year-old man. He had been floundering at home with his parents, failing at one job after another, and drifting aimlessly in schizophrenic fashion. His father was his symbiotic partner, frantically trying to bail him out of difficulties, prop him up, and direct his life. When the father died suddenly, Tom's passive-dependent and fragile mother could offer little support to her son. Tom began wandering the city and was literally picked up off the streets by Ms. M., a young woman who had left her young children with her estranged husband to start a shelter for the homeless. Tom became her most steadfast client, and Tom's family supported this. It was as if they had hired a surrogate symbiotic partner for Tom, to protect his infirm mother. Tom was very attracted to Ms. M. but also rebelled against her authoritarian ways, as he had done with his father. He tried to re-establish his relationship with his father's associates, particularly at an exclusive club where he had accompanied his father on many occasions. He was thrown out by security guards who found his behavior inappropriate and hostile. He What followed felt like an assault which could be understood as the system resisting a threatening change. Prior to the meeting at which these "significant others" were to be present, I received a call from a Secret Service agent inquiring about Tom's treatment. While the agent was proper and respectful, this had a somewhat intimidating effect on me. Ms. M. also called, demanding that she be informed of any change in Tom's medication. She said that if she were not treated more like a colleague, she would pull Tom out of the program. Tom's mother and brother, who had been attending the group for significant others regularly and had been supportive of the program, were cold and hostile when they brought the lawyer to the meeting. Tom Thus, a system's conceptual framework can enable the pharmacotherapist to sort out and work with the complex intrapsychic, interpersonal, inter-familial, institutional, and societal forces that are often set in motion by the transactions that surround prescribing psychoactive medication. These forces can have a profound effect on the psychosocial therapeutic process. There is no doubt that psychoactive medication can be a powerful facilitator of therapy, particularly when it is used by the patient as a resource over which he exerts choice and control, rather than one which he is subjected to or is forced to comply with. On the other hand, the same medication, even at the same doses, can be fused with forces within and outside the patient that are aimed at destroying experience and keeping the patient locked ih a sick and discredited role. The subtle and overt self-serving pressures in the system to view schizophrenia as mainly disordered chemistry may help to control or abort psychosis, but they can also insidiously reinforce and perpetuate the schizophrenic problem. It is not just the medication that needs to be metabolized by the patient. The dynamic forces within the system must be metabolized by the pharmacotherapist and in a coherent way brought back into the treatment if the patient is to be helped by medication and not harmed.
